-
Value-Based Pricing in 2012 – Is it Still Worth the Trouble?: As the old aphorism goes, a New Year means a new beginning. It also provides an opportunity for all of us to make New Year resolutions – promises we make to one or more lasting personal goals, projects, or the reforming of a habit. In the world of health policy, this has added meaning. The Government continues to face opposition to its NHS reforms. read more
value-based pricing | VBP | Stuart Carroll
Advertisement
Events of Interest
-
Global Pharmaceutical Distribution 2012
Venue to be Confirmed, Amsterdam, The Netherlands
September 18- 19, 2012 -
Cool Chain Logistics 2013
Congress Center Basel, Basel, Switzerland
January 28- 30, 2013 -
Information Governance & eDiscovery for Pharma, Biotech and Medical Devices
London, UK
June 26- 28, 2012 -
Cold Chain Global Forum 2012
Chicago, IL
September 24- 28, 2012
Articles
-
Contributor: Andrea Charles
Global Clinical Outsourcing Forum – Avoids Death by PowerPoint with New Format – Round Up: GCOF took brave step this year and was un-conferenced. The 3rd Annual Global Cli... read more
Tags: clinical outsourcing | global clinical outsourcing | Global Clinical Outsourcing Forum
-
Contributor: Joe Liscouski
Smooth the Path to Integration in Informatics: With an increasing emphasis on informatics and the potential to better organize and manage... read more
Tags: Informatics | Standards | integration
-
Contributor: Niamh Madigan
6 Tips to Achieving the Impossible in the Face of Change: Let’s face it, we live in a world that is constantly changing and nowhere ... read more
Tags: change | impossible | possible
-
Contributor: Runa Mookerjee
US Healthcare Regulation, Technology Advancements Spell Boom for Outsourcing: Advancements in healthcare technology, apart from improvement of quality of care, are almo... read more
Tags: electronic medical record | EMR | electronic health record
-
Contributor: James Harris
Biosimilars Landscape and FDA Regulatory Expectations: The Congressional Budget Office (CBO) has estimated that the United States could save $25 ... read more
Tags: biosimilars | FDA | FDA regulatory expectations
|
Reach Pharma professionals through cost-effective marketing opportunities to deliver your message, position yourself as a thought leader, and introduce new products, techniques and strategies to the market.
Learn More >> Join today and interact with a vibrant network of pharma professionals, keeping up to date with the pharma industry by accessing our wealth of Pharma articles, videos, online seminars, live conferences and more. Sign Up Today! |
| Pharma IQ, a division of IQPC 2012 All rights reserved. Use of this site constitutes acceptance of our User Agreement and Privacy Policy. Careers With IQPC | Contact Us | Unsubscribe to Bizo | About Us |
|
Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!